Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-25-003241

CEO and Chairman sold 285,187 shares at an average $8.45 ($2,410,700)

  • CEO and Chairman acquired 285,187 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-19 Exercise or conversion : show line 1 in the form 10b5-1 +186,080 $6.32 $1,176,026 2,762,781 D
2025-02-19 Sale : show line 2 in the form 10b5-1 −186,080 $8.46 $1,574,237 2,576,701 D
2025-02-20 Exercise or conversion : show line 3 in the form 10b5-1 +99,107 $6.32 $626,356 2,675,808 D
2025-02-20 Sale : show line 4 in the form 10b5-1 −99,107 $8.44 $836,463 2,576,701 D
Open-market sales · 285,187 sh · avg $8.45 · $2,410,700

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2025-02-19 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −186,080 99,107 D
2025-02-20 Exercise or conversion : show line 6 in the form 10b5-1 Stock Option (right to buy) −99,107 0 D
Loading xslF345X05/form4.xml…